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Abstract. 
 
Structural protein 4.1, first identified as a 
crucial 80-kD protein in the mature red cell membrane 
skeleton, is now known to be a diverse family of protein 
isoforms generated by complex alternative mRNA 
splicing, variable usage of translation initiation sites, 
and posttranslational modification. Protein 4.1 epitopes 
are detected at multiple intracellular sites in nucleated 
mammalian cells. We report here investigations of pro-
tein 4.1 in the nucleus. Reconstructions of optical sec-
tions of human diploid fibroblast nuclei using antibod-
ies specific for 80-kD red cell 4.1 and for 4.1 peptides 
showed 4.1 immunofluorescent signals were intranu-
clear and distributed throughout the volume of the nu-
cleus. After sequential extractions of cells in situ, 4.1 
epitopes were detected in nuclear matrix both by im-
munofluorescence light microscopy and resinless sec-
tion immunoelectron microscopy. Western blot analysis 
of fibroblast nuclear matrix protein fractions, isolated 
under identical extraction conditions as those for mi-
croscopy, revealed several polypeptide bands reactive 
to multiple 4.1 antibodies against different domains. 
Epitope-tagged protein 4.1 was detected in fibroblast 
nuclei after transient transfections using a construct en-
coding red cell 80-kD 4.1 fused to an epitope tag. En-
dogenous protein 4.1 epitopes were detected through-
out the cell cycle but underwent dynamic spatial 
rearrangements during cell division. Protein 4.1 was ob-
served in nucleoplasm and centrosomes at interphase, 
in the mitotic spindle during mitosis, in perichromatin 
during telophase, as well as in the midbody during cy-
tokinesis. These results suggest that multiple protein 
4.1 isoforms may contribute significantly to nuclear ar-
chitecture and ultimately to nuclear function.
 
S
 
tructural
 
 proteins via diverse molecular interac-
tions determine cell morphology, organize subcellu-
lar compartments, stabilize cell attachments, and
even regulate essential cellular responses to internal or ex-
ternal signaling. The 80-kD structural protein, protein 4.1,
was initially characterized as a crucial member of the red
cell membrane skeleton where it stabilizes complexes be-
tween spectrin and actin within the skeletal network and
anchors them to the overlying plasma membrane through
interactions with integral membrane proteins. Deficiencies
in 80-kD protein 4.1 profoundly alter red cell morphology
and decrease membrane mechanical strength, leading to
membrane fragmentation and hemolytic anemia.
In subsequent studies, the 80-kD 4.1 of mature red cells
was identified as only one member of a large protein 4.1
family that is relatively abundant in nucleated erythroid and
nonerythroid cells. In fact, Western blots of many types of
mammalian and avian cells revealed 4.1 immunoreactive
protein species ranging from 30–210 kD (Anderson et al.,
1988; Granger and Lazarides, 1984, 1985). As in many
other structural protein families, 4.1 isoform structural and
functional diversity can be generated by a number of mecha-
nisms including complex alternative splicing of 4.1 pre-
mRNA (Conboy et al., 1988, 1991; Tang et al., 1988, 1990),
usage of at least two translation initiation sites, and post-
translational modifications of 4.1 proteins. These varia-
tions as well as regulated 4.1 mRNA expression can be both
tissue- and differentiation-specific (for review see Conboy,
1993).
Several binding partners for specific 4.1 domains have
been characterized. The amino-terminal domain of eryth-
rocyte protein 4.1 contains binding sites for glycophorin C,
calmodulin, p55 (Kelly et al., 1991; Tanaka et al., 1991;
Pinder et al., 1993; Gascard and Cohen, 1994; Hemming
et al., 1994, 1995; Marfatia et al., 1994, 1995), and band 3
(Jons and Drenckhahn, 1992; Lombardo et al., 1992), while
a domain towards the COOH terminus contains binding
sites for spectrin and actin complexes (Correas et al.,
1986
 
a
 
,
 
b
 
; Discher et al., 1993; Schischmanoff et al., 1995).
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Purified red cell 4.1 also interacts specifically with tubulin
(Correas and Avila, 1988) and myosin (Pasternack and
Racusen, 1989). The multiplicity of 4.1 isoforms combined
with the diversity of possible protein–protein interactions
suggests that individual 4.1 isoforms may have specific and
discrete functions. However, the roles of 4.1 isoforms,
other than in red cells, have not yet been defined.
In contrast to the strictly peripheral localization of 4.1 in
mature red cells, 4.1 epitopes in nucleated cells have been
observed by immunofluorescence throughout the cyto-
plasmic compartment (Cohen et al., 1982; Lue et al., 1994),
including perinuclear regions such as apparent centroso-
mal and Golgi structures (Leto et al., 1986; Marchesi, V.T.,
S. Huang, T.K. Tang, and E.J. Benz. 1990. 
 
Blood.
 
 76:12A;
Chasis et al., 1993; Krauss, S.W., C.A. Larabell, C. Rogers, N.
Mohandas, and J. Chasis. 1995. 
 
Blood.
 
 86:415a; Beck,
K.A., and W.J. Nelson. 1996. 
 
Mol. Cell. Biol.
 
 302:22). Immu-
nolabeling of 4.1 epitopes has also been observed in the
nucleus (Madri et al., 1988; Tang, T.K., C.E. Mazoucco,
T.L. Leto, E.J. Benz, and V.T. Marchesi. 1988. 
 
Clin. Res.
 
36:A405; Marchesi, V.T., S. Huang, T.K. Tang, and E.J.
Benz. 1990. 
 
Blood.
 
 76:12A; Correas, 1991; Krauss, S.W. 1994.
 
J. Cell. Biochem.
 
 18c:95, M208; Krauss, S.W., J.A. Chasis,
S. Lockett., R. Blaschke, and N. Mohandas. 1994. 
 
Mol.
Biol. Cell.
 
 5:343a; De Carcer et al., 1995; Krauss, S.W., J.A.
Chasis, C.A. Larabell, S. Lockett, R. Blaschke, and N. Mo-
handas. 1995. 
 
J. Cell Biochem.
 
 21B:140, JT 309). Isoforms
of protein 4.1 in the nucleus presumably could serve as
structural elements. This is particularly intriguing in light
of emerging evidence of the important relationship between
nuclear architecture and regulation of nuclear functions.
The nucleus contains an internal nonchromatin scaffold-
ing called the “nuclear matrix” or “nucleoskeleton.” The
nuclear matrix is a three-dimensional structure, and when
viewed using resinless section electron microscopy, it
appears as a network of polymorphic filaments enmeshing
larger masses or “dense bodies” (Capco et al., 1982; Fey
et al., 1986; Nickerson et al., 1995; for review see Penman,
1995). Matrix spatial organization appears to provide func-
tional subcompartmentalization for nuclear metabolic pro-
cesses and requisite machinery (Nakamura et al., 1986; Spec-
tor, 1990, 1993; Carmo-Fonseca et al., 1991; Saunders et
al., 1991; Spector et al., 1991; Wang et al., 1991). The larg-
est nuclear domains are the nucleoli, sites of ribosomal
RNA synthesis and partial assembly (Fischer et al., 1991;
Scheer et al., 1993). RNA transcription and pre-mRNA
splicing occur in smaller domains and along tracks within
the matrix reticular network (Spector, 1990; Spector et al.,
1991; Carter et al., 1993; Xing et al., 1993, 1995). DNA is
attached to the nuclear skeleton, and factors involved in
replication and cell cycle control are clustered into dis-
crete replication foci (Smith and Berezney, 1982; Jackson
and Cook, 1986; Cook, 1988; Leonhardt et al., 1992; Hozak
et al., 1993). However, during each round of cell division,
the nucleus itself undergoes dramatic morphologic remod-
eling: its nuclear envelope dissolves, the underlying lamin
ring depolymerizes, and chromosomes condense. Thus,
the nuclear scaffold must be capable of a series of ordered
yet dynamic protein–protein interactions necessitated by
perturbations of nuclear architecture and function during
the cell cycle.
We report here that protein 4.1 isoforms are resident
proteins of the nucleoskeleton during interphase and un-
dergo dynamic reorganization in their association with nu-
clear components during mitosis. This suggests that by mo-
lecular interactions either previously identified or entirely
novel, protein 4.1 isoforms could be integral both to nu-
clear structure and to modulation of nuclear activities.
 
Materials and Methods
 
Materials
 
WI38 cells (CCL 75: diploid human fetal lung fibroblasts), CaSki cells
(CRL 1550: human cervical epidermoid carcinoma), and 3T3 cells (CCL 92:
murine fibroblasts) were obtained from American Type Culture Collec-
tion (Rockville, MD). HCA cells, from human fetal foreskin, were the gift
of Dr. J. Campisi (Lawrence Berkeley National Laboratory, Berkeley,
CA). The plasmid pSV2NeoCMV was generously provided by Dr. P. Yaswen
(Lawrence Berkeley National Laboratory). The vector contains a cytomeg-
alovirus (CMV)
 
1
 
 promoter, SV-40 polyA addition and splice signals, and
an EcoRI restriction site for insertion of test sequences. B4A11 mono-
clonal antiserum was the gift of Dr. J.A. Nickerson (Massachusetts Insti-
tute of Technology, Cambridge, MA). FITC-conjugated goat anti–rabbit
IgG and 5-(and-6)-carboxy-rhodamine succinimidyl ester were purchased
from Molecular Probes (Eugene, OR). Tetramethyl-rhodamine–conju-
gated goat anti–mouse IgG and fluorescein 5-isothiocyanate isomer 1 were
from Sigma Chemical Co. (St. Louis, MO). Anti–
 
b
 
-tubulin and high mo-
lecular weight “Rainbow” markers were products of Amersham Corp.
(Arlington Heights, IL). Pefabloc (AEBSF; 4-[2 aminoethyl]benzenesulfonyl
fluoride) was obtained from Boehringer Mannheim Corp. (Indianapolis,
IN). Renaissance chemiluminescence reagents were purchased from Du-
Pont/NEN (Boston, MA). DME and LipofectAMINE were the product
of GIBCO BRL (Gaithersburg, MD) and FBS was from Hyclone Labs
(Logan, UT). Antibodies against lamin B (Ab-1), PCNA (Ab-1), nuclear
mitotic apparatus protein (NuMA) (Ab-1), and nuclear pores (Ab-3) were ei-
ther purchased or provided by Oncogene Research (Cambridge, MA).
 
Western Blot Analysis
 
Protein samples separated on 7% SDS-PAGE were transferred to nitro-
cellulose for 7 h at 100 V. After blocking, the blots were incubated first
with 0.5 
 
m
 
g/ml primary IgG for 1 h at room temperature, washed, and then
incubated with a secondary antibody coupled to horseradish peroxidase.
Immunoreactive proteins were visualized by chemiluminescent autora-
diography.
 
Immunofluorescence
 
Subconfluent WI38 fibroblasts or CaSki cells grown on coverslips were
rinsed twice in PBS at pH 7.4, fixed for 10 min at 4
 
8
 
C in PBS containing
2% formaldehyde/0.2% Triton X-100, further permeabilized with 1% Tri-
ton X-100 for 10 min at room temperature, and then rinsed twice in PBS.
Alternatively, cells were fixed in 
 
2
 
80
 
8
 
C acetone or in cold MeOH for 5
min. After incubation in 10% goat serum to block nonspecific protein
binding, fixed cells were incubated with 5–10 
 
m
 
g/ml primary antibodies for
1 h at room temperature in PBS containing 10 mg/ml BSA, washed, and
then incubated with FITC- and rhodamine-conjugated secondary antibod-
ies. Cells were stained with 4
 
9
 
,6-diamidino-2-phenylindole (DAPI) at 0.5
 
m
 
g/ml (Sigma Chemical Co.) to confirm nuclear location and washed again,
and the coverslips were mounted on slides using Vectashield (Vector Lab-
oratories, Burlingame, CA). Controls with equivalent amounts of nonim-
mune IgG or with primary antibody omitted were also included in each
experiment. When photographed under the same conditions as the exper-
imental samples, the controls did not show fluorescence.
 
Microscopy
 
Immunofluorescent cells were photographed using an epifluorescence mi-
croscope with a 63
 
3
 
 objective and a 1.4 NA oil immersion lens. A micro-
scope (model Axioplan; Carl Zeiss, Inc., Thornwood, NY) equipped with
 
1. 
 
Abbreviations used in this paper
 
: CMV, cytomegalovirus; DAPI, 4
 
9
 
6-
diamidino-2-phenylindole; GST, glutathione-S-transferase; NuMA, nu-
clear mitotic apparatus protein; PCNA, proliferating cell nuclear antigen. 
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a 63
 
3
 
 1.3 Neofluor oil immersion lens, a Quantitative Image Processing
System based on the MicroImager 1400 digital camera (Xillix Technolo-
gies Corp., Vancouver, BC, Canada), and the Scil-Image image analysis
software package (The University of Amsterdam, The Netherlands) were
used to acquire and analyze 0.2-
 
m
 
m optical sections of cells. A confocal
scanning laser microscope (model MRC 1000; BioRad Labs, Hercules,
CA) equipped with a Nikon Diaphot 200 (Melville, NY), a fluor 60
 
3
 
 1.4
planapo oil immersion lens, and a krypton/argon laser was also used to ob-
tain 0.5-
 
m
 
m optical sections. Double-label images were collected sequen-
tially and both signals were of similar intensity. Confocal images were con-
structed by means of BioRad software.
High resolution resinless section EM of immunostained cells was per-
formed as previously described (Capco et al., 1984; Nickerson et al., 1990,
Nickerson and Penman, 1992). Extracted cells were fixed with glutaralde-
hyde, blocked with goat serum, labeled with gold bead–conjugated goat
anti–rabbit secondary antibodies (Amersham Corp.) after incubation with
primary IgG, and fixed again. The samples were embedded in diethylene
glycol distearate (Polysciences, Warrington, PA). Thin sections were cut,
and the resin was removed before critical point drying and carbon coating.
Resinless sections were examined using an electron microscope (model
1200EX; JEOL U.S.A., Inc., Peabody, MA).
 
Cell Culture
 
WI38 cells were grown in a 5% CO
 
2
 
 incubator at 37
 
8
 
C in DME and CaSki
cells in RPMI-1640 medium containing 10% FCS, 4 mM glutamine, antibi-
otics (50 U/ml penicillin and 50 
 
m
 
g/ml streptomycin) and 2.2 g/liter sodium
bicarbonate. Human fibroblasts were used at passages 20–24 where 
 
.
 
90%
were capable of DNA synthesis.
 
Preparation of Nuclear Matrix Proteins
 
For isolation of nuclear matrix from nuclei, proliferating cells were tryp-
sinized, washed three times in PBS, swollen in RSB (10 mM Tris, pH 7.4,
10 mM NaCl, 3 mM MgCl
 
2
 
) for 30 min on ice, and dounced in RSB con-
taining 0.3% NP-40 for about ten strokes until nuclei were free of cyto-
plasm by microscopic examination. Nuclei were then pelleted through a
0.25 M sucrose-RSB cushion for 10 min at 1500 
 
g
 
 at 4
 
8
 
C. Typically, 
 
.
 
95%
of nuclei were recovered. Sequential extraction procedures were per-
formed as described previously (Fey et al., 1984, 1986; Nickerson et al., 1994)
using buffers containing protease inhibitors (1 mM Pefabloc, 0.1 
 
m
 
g/ml
aprotinin, 1 
 
m
 
g/ml pepstatin and leupeptin). Briefly, nuclei were succes-
sively extracted in CSK buffer (10 mM Pipes, pH 6.8, 300 mM sucrose, 100
mM NaCl, 3 mM MgCl
 
2
 
, 1 mM EGTA, and 0.5% Triton X-100), extrac-
tion buffer (10 mM Pipes, pH 6.8, 300 mM sucrose, 250 mM ammonium
sulfate, 3 mM MgCl
 
2
 
, 1 mM EGTA, and 0.5% Triton X-100), digestion buf-
fer (10 mM Pipes, pH 6.8, 300 mM sucrose, 50 mM NaCl, 3 mM MgCl
 
2
 
, 1 mM
EGTA, and 0.5% Triton X-100) with DNase and RNase or RNase-free
DNase as indicated, and reextracted with 250 mM ammonium sulfate. To
remove additional proteins from nuclear matrix, the preparation was ex-
tracted with 2 M NaCl buffer. For fractionation of nuclear matrix for in
situ microscopy, subconfluent cells growing on coverslips were rinsed in
PBS and sequentially processed as described above.
 
Antibodies
 
Rabbits were immunized with 80-kD protein 4.1 purified from human
RBC or with synthetic peptides comprised of sequences encoded by either
exon 16 (peptide 10-1), exon 19 (peptide 24-2), or exon 21 (peptide 24-3)
coupled to thyroglobulin (see Fig. 1). Sequences of the peptide antigens
were: 10-1, KKRERLDGENIYIRHSNLMLEC; 24-2, TDDNSGDLD-
PGVLLTAQTITSETPSSTTTTQITKC; or 24-3, HPDMSVTKVVVH
QETEIADEC. In addition, the sequence encoding peptide N-2, contain-
ing 209 amino acids following the AUG-1 start site of translation of pro-
tein 4.1 (Conboy et al., 1991) (Fig. 1), was fused to glutathione-S-trans-
ferase (GST). The construct was overexpressed, purified by glutathione
agarose affinity chromatography, and used for immunization. Immune
IgGs were affinity purified against the immunizing 4.1 peptide or RBC
80-kD 4.1 and analyzed to confirm no cross-reaction with either thyroglob-
ulin or the GST moiety. Antibodies 10-1 and 24-2 have been used by us in
other studies (Chasis et al., 1993; Conboy et al., 1993; Schischmanoff et al.,
1995; Chasis et al., 1996). For direct labeling, IgGs (0.4 
 
m
 
g/ml) were conju-
gated to rhodamine or FITC fluorophores and then extensively dialyzed
according to the instructions provided by Molecular Probes.
 
PCR Amplification of Protein 4.1 mRNA
 
WI38 mRNA, prepared from early passage, proliferating cells by the
guanidinium thiocyanate method (Chirgwin et al., 1979) and human retic-
ulocyte mRNA prepared as described (Temple et al., 1977) were tran-
scribed into cDNA and amplified by PCR under the conditions previously
used by Conboy et al. (1991). For amplification of AUG-1, the oligonucle-
otides used were: sense strand, AACATCATGACAACAG, and anti-
sense strand, GTGTGTTTCTGCACTGCTTA.
 
Transient Transfections
 
A DNA construct was engineered encoding the sequence for 80-kD 4.1
fused at its COOH terminus to an epitope tag (KPPTPPPEPET) derived
from SV-40 large T antigen. The 80-kD 4.1 sequence began at AUG-2 and
included coding sequence through exon 21 except for the alternatively
spliced exons 14, 15, 17A, and 17B. The tag sequence, detected with the
monoclonal antibody KT3 (MacArthur and Walter, 1984), does not con-
tain the SV-40 nuclear localization signal. The 80-kD 4.1 epitope-tagged
construct was fused to GST in pGEX-KT and expressed in 
 
Escherichia
coli
 
, and the product was isolated by glutathione chromatography (Dis-
cher et al., 1993). It was analyzed by Western blotting to verify its appar-
ent molecular weight and reactivity both with 4.1 and KT3 antibodies.
Subconfluent murine fibroblasts (3T3 cells) growing on coverslips were
transfected using LipofectAMINE and plasmid DNA according to the
manufacturer’s instructions. A CMV-
 
b
 
-gal vector was used to optimize trans-
fection conditions. 3T3 cells were transfected for 24–48 h with pSV2NeoCMV
containing an insert encoding 80-kD red cell protein 4.1 fused to an
epitope tag at its COOH terminus or a control vector without an insert.
Transfected 3T3 cells were fixed either with paraformaldehyde or metha-
nol, processed for indirect immunofluorescence using Texas red–conju-
gated secondary antibody, and finally DAPI stained to determine subcel-
lular distribution of expressed epitope-tagged protein. Three independent
transient transfection experiments were performed.
 
Results
 
Protein 4.1 Localizes to Intranuclear Sites
 
To investigate nuclear localization of protein 4.1, we ini-
tially used diploid human fibroblasts (WI38 cells) since their
flattened morphology is particularly amenable by micros-
copy to distinguish nucleus versus cytoplasm and since hu-
man fibroblasts do not spontaneously transform in culture.
Multiple protein 4.1 isoforms have previously been ob-
served in fibroblasts (Cohen et al., 1982; Conboy et al., 1993).
To detect 4.1 epitopes by immunofluorescence micros-
copy, we used a panel of affinity-purified IgGs. As de-
picted by the map of multiple alternative splicing path-
ways in Fig. 1 
 
A
 
, protein 4.1 isoforms contain varying
patterns of exonic inclusion and exclusion. Using exon-
specific antibodies allows detection of 4.1 isoforms having
the peptide encoded by that particular exon. Our antibody
panel included antibody 10-1, recognizing sequence encoded
by exon 16; antibody 24-2, specific for peptide encoded by
exon 19; antibody 24-3, recognizing epitope encoded by exon
21; antibody N-2, recognizing the NH
 
2
 
-terminal 209 amino
acids translated from the AUG-1 start site (Fig 1, 
 
B
 
 and 
 
C
 
);
and anti-RBC 80-kD, against the 80-kD red cell 4.1 isoform
purified from human RBC (Fig. 1 
 
B
 
). We established the
specificity of our antibody panel for protein 4.1 by showing
that IgGs 10-1, 24-2, 24-3, and anti-RBC 80-kD 4.1 each
reacted with red cell 80-kD 4.1 in Western blot analysis
(Fig. 2 
 
A
 
) and with protein 4.1 in the plasma membrane of
human red cells using immunofluorescent detection (Fig. 2
 
B
 
). Furthermore, immunofluorescent signals were coinci-
dent when human red blood cells were probed with 24-2 
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Figure 1. Protein 4.1 peptide
domains used to generate an-
tibodies. (A) A schematic di-
agram of protein 4.1 mRNAs
displaying multiple combina-
tions of splicing pathways
possible among 4.1 alterna-
tive exons. In this format, ex-
ons are coded as follows:
solid bars, constitutive;
shaded bars, alternative;
open bars, noncoding. The
arrows on top indicate the
positions of alternative trans-
lation initiation sites, AUG-1
and AUG-2. The figure is de-
rived from Conboy et al.
(1991). (B) Examples of pro-
tein 4.1 isoforms derived
from different translation ini-
tiation sites. The 80-kD prototypical red cell isoform is produced from AUG-2 and can be present in nucleated and nonnucleated cells.
Chymotryptic fragments of this isoform include a 30-kD membrane binding domain, a 16-kD domain, a 10-kD spectrin and actin bind-
ing domain, and the 22–24-kD domain (Leto and Marchesi, 1984). Higher molecular mass 4.1 isoforms, present in nucleated cells, use
AUG-1 to generate an additional 209–amino acid “NH2-terminal extension” (N-term). (C) Synthetic peptides derived from the 4.1
amino acid sequence at the positions indicated by the arrows were used to immunize rabbits. IgGs were prepared from N-2, 10-1, 24-2, and
24-3 sera by affinity purification using the homologous peptide. The sequences for the peptides are given in the Methods section.
Figure 2. Characterization of antibodies directed against red cell 80-kD 4.1 and 4.1 peptide domains. (A) Human red cell membrane
fractions (Conboy et al., 1993) were separated by SDS-PAGE, transferred to nitrocellulose, and incubated with the following IgGs:
lane 1, anti-RBC 4.1; lane 2, anti–N-2; lane 3, anti–10-1; lane 4, anti–24-2; lane 5, anti–24-3; lane 6, control IgG. Protein 4.1 in red cells mi-
grates at z80 kD. Although this is the predominant 4.1 isoform in red cells, a faint band at z135 kD detected by anti–N-2 (lane 2) is also
detected by other 4.1 IgGs when increased amounts of red cell membrane preparations are applied to gels (Conboy et al., 1991). (B) Hu-
man red cells were fixed by methanol and probed by indirect immunofluorescence using primary antibodies as indicated and FITC-
conjugated secondary antibodies. The faint staining by anti–N-2 most likely reflects the small amount of z135-kD 4.1 also detected by
Western blot analysis of red cell membranes. Bar, 10 mm. 
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and 24-3 directly labeled with two different fluorophores
(see Fig. 4).
Using three different classical fixation techniques (para-
formaldehyde, methanol, or acetone), prominent punctate
staining in the nuclear area of WI38 fibroblasts was consis-
tently observed by indirect immunofluorescence with each
antibody. Some antibodies also generated a more diffuse
nuclear staining pattern and several of the antibodies pro-
duced cytoplasmic staining (Fig. 3). Parallel samples incu-
bated with control IgG did not produce nuclear immuno-
fluorescence with any of these fixation methods (Fig. 3).
Fibroblasts were also probed with preparations of 24-2 or
24-3 IgGs directly labeled with either of two different fluo-
rophores; these cells displayed immunofluorescent pat-
terns similar to those obtained by indirect methods (data
not shown). Nuclear immunofluorescent staining was also
observed when another human fibroblast line (HCA), a
transformed epithelial human line (CaSki; see Fig. 9) and
a transformed murine fibroblast line (3T3; see Fig. 8) were
probed with the 4.1 antibody panel.
The nucleus is bounded by two concentric lipid bilayers
perforated by nuclear pores and an underlying ring of
lamin, a specialized intermediate filament. Nuclear-associ-
ated 4.1 immunofluorescent signals could have arisen from
cytoplasmic epitopes overlying the nucleus, from nuclear
membrane sites, or from interior nuclear locations. In fact,
since 80-kD protein 4.1 in mature erythrocytes is a compo-
nent of the plasma membrane skeleton (Fig. 4), one might
predict that 4.1 would localize to the nuclear membrane or
even the underlying lamin protein ring. To distinguish
among these possibilities, double-label confocal micros-
copy was performed to localize 4.1 foci relative to epitopes
for two well-characterized nuclear proteins, lamin B and the
nuclear pore complex. Optical horizontal sections through
the center of the nucleus revealed well-separated rhoda-
mine (Fig. 5 
 
A
 
, stain for lamin; Fig. 5 
 
B
 
, stain for pores)
and FITC (stain for 4.1) signals, leading to the conclusion
that 4.1 epitopes are within the area bounded by nuclear
pores embedded in the nuclear membrane and by the un-
derlying lamin protein ring. Furthermore, the smooth cir-
cumferential staining of both pores and lamin in the prep-
arations rules out the possibility that internal 4.1 foci are
Figure 3. Detection of nuclear epitopes of protein 4.1 by immunofluorescent light microscopy in WI38 cells. Cultured WI38 human fi-
broblasts were fixed in acetone for probing with anti-RBC 80-kD 4.1 and N-2, in methanol for probing with anti–24-2, or in formalde-
hyde for probing with anti–10-1 and anti–24-3, followed by incubation with a FITC-labeled secondary antibody. Punctate nuclear sig-
nals, detected with all the protein 4.1 antibodies, were particularly prominent with anti-RBC 80-kD 4.1 and anti–24-2. Localization of
FITC signals within the nuclei of all cells was confirmed by comparison to DAPI fluorescence of the cells with 4.1 fluorescence (not
shown). Antibodies N-2, 10-1, and 24-3 also produced considerable cytoplasmic staining. Staining patterns were in large part independent
of the fixation method. Controls showed no fluorescent patterns when imaged under the same conditions as experimental samples. Bar, 10 mm. 
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Figure 4. Coincidence of immu-
nofluorescent signals on human
red cells probed with antibodies
against two 4.1 peptide domains.
Normal human red cells, which
contain 80-kD 4.1 in their
plasma membrane, were fixed in
methanol and probed with anti-
body 24-2 directly conjugated to
a FITC fluorophore (green) and
antibody 24-3 directly conju-
gated to a rhodamine fluoro-
phore (red). The yellow image
indicates that the red and green
signals coincide. Bar, 6 mm.
 
Figure 5.
 
Distribution of protein 4.1 epitopes in the interphase nucleus of human fibroblasts visualized by immunofluorescence. Loca-
tion of the nucleus was confirmed in all cases by DAPI staining (not shown). (
 
A
 
 and 
 
B
 
) Double-label confocal microscopy of cells
stained by protein 4.1 antibody 24-2 (
 
green
 
) and (
 
A
 
) antibody against nuclear pores (
 
red
 
) or (
 
B
 
) lamin B (
 
red
 
). The majority of nuclear
protein 4.1 foci are interior to the periphery of the nucleus as demarcated by immunofluorescence of pores within nuclear membrane
and by its subadjacent network of lamin B fibers. (Additional lamin B sites in the nuclear interior have been reported [Bridger et al.,
1993; Moir et al., 1994]). Similar results were obtained by imaging epitopes for protein 4.1 antibodies 24-3, 10-1, and N-2 relative to antipore
and antilamin epitopes. (
 
C
 
) Three-dimensional image analysis of nuclear epitopes probed with anti-RBC 80-kD 4.1 showing a 0.3-
 
m
 
m
horizontal optical midsection of an immunofluorescent cell with a line indicating the position of the vertical reconstruction depicted in
 
C
 
9
 
. Since optical resolution in the z-axis (vertical) is less than in the x-y (horizontal) axis, the reconstructed image is less sharp; the dome
shape of the top of the cell and the flat bottom plane of the coverslip are somewhat obscured by the coincidence of out of focus light. (A
cartoon depicting the approximate shape of the vertical cross-section through the nucleus is presented in the bottom panel.) Thus, it is ap-
parent that epitopes for protein 4.1 lie in numerous planes within the volume of the cell. Similar results were obtained in three-dimen-
sional reconstructions using the 24-2, 24-3, and 10-1 antibodies as probes. (
 
D
 
 and 
 
D
 
9
 
) Double-label confocal microscopy of a fibroblast
using anti–24-2 (
 
green
 
) and anti-NuMA (
 
red
 
). In a horizontal plane through the midsection of the cell (
 
D
 
), protein 4.1 foci appeared
within the NuMA-stained nuclear interior. (
 
D
 
9
 
) Three-dimensional reconstructions were made of three different vertical planes from
this NuMA:24-2 double-labeled cell. The flattened plane of the coverslip appears at the top of the vertical reconstructed images. The
conclusion that 4.1 epitopes localized at multiple planes throughout the volume of the nucleus is entirely consistent with the observations
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being generated by invaginations of the nuclear membrane.
To further characterize the distribution of 4.1 within the
nucleus, fibroblast nuclei stained with IgGs against 4.1
peptide domains were optically sectioned into horizontal
planes using conventional and confocal immunofluores-
cence microscopy, and the information was digitized. Us-
ing image analysis software, three-dimensional reconstruc-
tions were made through vertical planes of the nuclear
interior. As illustrated in Fig. 5 C, 4.1 foci detected in hori-
zontal planes are at multiple levels within the nucleus
when analyzed by vertical cuts through horizontal layers
(Fig. 5 C9). This observation was confirmed by a double-
label experiment in which nucleoplasm, highlighted by
rhodamine with an antibody probe against a generally dis-
tributed nuclear matrix protein NuMA (nuclear mitotic
apparatus protein; Lydersen and Pettijohn, 1980; Comp-
ton et al., 1992; Yang et al., 1992), was imaged relative to
4.1 epitopes detected by FITC labeling (Fig. 5 D). The
confocal optical vertical sections show 4.1 epitopes to be
scattered throughout the nucleoplasm (Fig. 5 D9).
To determine whether 4.1 foci colocalize with nuclear
domains involved with pre-mRNA splicing factors or with
DNA replication, additional double-label immunofluores-
cence experiments were performed. Nuclear 4.1 epitopes
were imaged relative to SC-35 splicing protein (Fu and
Maniatis, 1992) and relative to proliferating cell nuclear anti-
gen (PCNA), an accessory protein for the replicative DNA
polymerase delta (Tan et al., 1986; Bravo et al., 1987; Pre-
lich et al., 1987) (Fig. 5, E–H). Although some coincident
fluorescent signals (denoted by pseudo yellow coloration)
were apparent in confocal horizontal planes through fibro-
blast nuclei stained for 4.1 (probed with FITC) relative to
either SC-35 or to PCNA (each probed with rhodamine-
labeled secondary antibody), each protein was also de-
tected alone. This is consistent with previous observations
that splicing and replication centers do not coincide with
each other (Leonhardt et al., 1992). Protein 4.1 foci were
not detected in areas occupied by nucleoli, seen as dark
round “holes” within the nucleus (Fig. 5 E). These data
show 4.1 epitopes to be generally distributed throughout
nonnucleolar nuclear domains involved in RNA and DNA
metabolism. Taken together, it is clear from the data in
Fig. 5 that 4.1 foci are intranuclear but do not localize pre-
dominantly at the nuclear membrane.
Identification of Protein 4.1 in Nuclear Matrix
Since 4.1 is an important structural protein in red cells, we
hypothesized that isoforms in the nucleus might biochemi-
cally cofractionate with nonchromosomal nuclear scaffold
proteins. To test this prediction, purified nuclear matrix
was prepared by established techniques using sequential
permeabilization, salt extraction, nuclease digestion, and
salt reextraction from cells grown on coverslips and also
from purified fibroblast nuclei (Capco et al., 1982; Fey et al.,
1986). Fibroblasts and CaSki cells retained epitopes recog-
nized by 80-kD RBC 4.1, 10-1, 24-2, and 24-3 antibodies
when monitored by immunofluorescence during each stage
of nuclear matrix preparation. When analyzed by three-
dimensional optical reconstructions, all extraction steps
before nuclease digestion displayed nuclear foci at multi-
ple planes. After completion of the matrix preparation,
there was no detectable staining with DAPI, attesting to
the near complete removal of chromatin. In contrast, im-
munofluorescent foci of 4.1 were retained in the matrix
preparation. Microscopic optical sectioning of these sam-
ples showed a collapsed nucleus so that, in contrast to pre-
vious extraction steps, all nuclear 4.1 epitopes resided on a
single plane.
Electron microscopy was used to achieve greater resolu-
tion in localizing 4.1 epitopes in the nucleus. Cells growing
on coverslips were prepared for embedment-free (“resin-
less”) section electron microscopy, a technique developed
specifically to image three-dimensional cytoplasmic and
nuclear structures normally concealed in conventionally
embedded samples (Capco et al., 1984; Nickerson and
Penman, 1992; Nickerson et al., 1994). Samples were se-
quentially extracted, lightly fixed, and incubated with pri-
mary IgGs against 4.1 peptides or normal rabbit IgG. A
secondary antibody coupled to gold beads was added, and
the preparation was fixed again and then embedded and
sectioned. After removal of the temporary embedding ma-
terial, epitopes for 4.1 were detected within the residual
nuclear matrix structures visualized by electron micros-
copy (Fig. 6), consistent with the results obtained with im-
munofluorescence assays run in parallel samples. At the
higher resolution of electron microscopy, the 4.1 epitopes
retained in nuclear matrix preparations were associated
with dense bodies and not with the supporting filamentous
network. Parallel samples incubated with control IgG did
not show labeling of nuclear structures.
Western Blot Analysis of Nuclear Matrix Proteins
To analyze nuclear-associated 4.1 isoforms, nuclear matrix
proteins isolated from purified fibroblast nuclei were sepa-
rated on SDS-PAGE and transferred to nitrocellulose,
and identical gel lanes were probed with each of the 4.1
antibodies. A number of protein bands in the matrix prep-
aration were reactive with multiple 4.1 IgGs. (Fig. 7 A,
lanes  1–5). Prominent clusters of bands migrating with mo-
lecular masses in the range of z55 and 80–100 kD were
detected. Other less abundant bands also reacted with
antibodies against several different protein 4.1 epitopes:
z65 kD (antibodies 24-2, 24-3) and z120–150 kD (anti-
bodies 10-1, 24-3, 4.1). No reaction with the nuclear matrix
Optical sections through the fibroblast nucleus show that 24-2 (green) and PCNA (red) epitopes coincided (yellow) in many areas except
in the vicinities of the nucleoli, which either are relatively devoid of any signal or sometimes contained a clustering of 24-2 (green) sig-
nals. Both PCNA and 24-2 epitopes resided in multiple planes throughout the nucleus (not shown). (G and H) Double-label confocal mi-
croscopy of cells probed with antibody 24-2 (green) and antibody against SC-35 (red). Optical sections are in the plane of the cell con-
taining SC-35 domains; most SC-35 domains in fibroblasts are located in a single plane (Carter et al., 1993). It is apparent that the vast
majority of the SC-35 domains contained areas of coincident staining with 24-2 (seen as yellow coloration), most often at the periphery
of the SC-35 domains. In optical sections above and below SC-35, additional 24-2 signals are observed (not shown), consistent with the
conclusions from the localization data presented in A–F. Bars, 3.5 mm (8 mm in the vertical dimension [C9 and D9]).The Journal of Cell Biology, Volume 137, 1997 282Krauss et al. Structural Protein 4.1 in the Nucleus 283
proteins occurred when control rabbit IgG was used as a
probe (Fig. 7 A, lane 6). Thus multiple isoforms of 4.1 are
retained in the most insoluble fraction of nuclear proteins.
To verify that the blotted proteins contained character-
istic nuclear matrix proteins, a lane was probed with anti-
body against a major nuclear matrix protein, lamin B. A
single band at the expected molecular mass of 66 kD was
detected (Fig. 7 A, lane 9). To assess cross-contamination
of nuclear matrix by cytoplasmic proteins, lanes containing
cytoplasmic and nuclear matrix fractions were probed with
antibody against the cytoplasmic protein b-tubulin (Fig.
7 A, lanes 7 and 8); b-tubulin could be detected only in the
cytoplasmic fraction (Fig. 7 A, lane 7) and not in the lane
containing nuclear matrix (Fig. 7 A, lane 8).
In both immunofluorescence and Western blotting ex-
periments with antibody N-2, the results reported above
suggest that 4.1 isoforms initiated at the upstream transla-
tion initiation site AUG-1 are expressed in fibroblasts. As
an independent means of confirming the existence of such
isoforms in fibroblasts, 4.1 mRNA was selectively ampli-
fied by reverse transcriptase–PCR techniques using prim-
ers designed to detect the AUG-1 sequence. As shown in
Fig. 7 B, WI38 fibroblast RNA encodes AUG-1, consistent
with the N-2 antibody results.
Furthermore, after Western blotting of nuclear matrix
using 24-2 and 24-3 IgGs, we detected several protein
bands with similar apparent molecular masses as well as
other bands not in common (Fig. 5, lanes 4 and 5). This re-
sult predicted nuclear 4.1 isoforms with differing combina-
tions of the 24-2 and 24-3 epitopes. Using preparations of
24-2 and 24-3 antibody each directly labeled with a differ-
ent fluorophore, double-label immunofluorescent staining
of fibroblasts revealed coincident signals in the nucleus
along with some noncoincident staining for each antibody
(data not shown). This result is consistent with data from
Western blot analysis of nuclear matrix proteins. Taken
together, immunofluorescent and Western blot data sug-
gest that there are multiple nuclear 4.1 isoforms or homo-
logues and that protein 4.1 fractionates with nuclear ma-
trix proteins.
Expression of Epitope-tagged 4.1 in the Nucleus
To test for protein 4.1 in the nucleus by a second experi-
mental strategy, a construct encoding the prototypical
80-kD protein 4.1 (Conboy et al., 1991; Tang et al., 1988,
1990) fused to an epitope tag was transiently transfected
into murine fibroblast 3T3 cells. Before transfection, we
Figure 6. Immunolocalization of protein 4.1 in nuclear matrix visualized by high-resolution resinless electron microscopy. CaSki cells
were extracted with 0.5% Triton X-100 in CSK buffer, chromatin was removed by HaeIII and PstI digestion, and proteins were ex-
tracted with 0.25 M ammonium sulfate followed by extraction with 2 M NaCl. After fixation, the matrix preparation was incubated with
protein 4.1 antibody 24-3 (A) and 24-2 (B) and then with colloidal gold–coupled secondary antibody. The EM micrograph of a resinless
section shows a network of nuclear matrix core filaments (CF) and dense bodies (DB). The 10-nm gold beads decorated principally the
periphery and some internal areas of the dense bodies (arrowheads). This localization pattern at dense bodies in the matrix was also ob-
served in a parallel experiment using anti–10-1 IgG but not with control IgG. Bar, 100 nm.
Figure 7. Analysis of fibroblast
nuclear matrix 4.1 protein by
Western blot and 4.1 mRNA by
reverse transcriptase–PCR. (A,
lanes 1–6) Nuclear matrix pro-
teins isolated from 3 3 106 WI38
nuclei were separated by SDS-
PAGE, transferred to nitrocel-
lulose, and incubated with the
following 4.1 antibodies: lane 1,
RBC 80-kD 4.1; lane 2, N-2; lane
3, 10-1; lane 4, 24-2; lane 5, 24-3;
lane 6, control IgG. To test the
relative separation of nuclear
matrix proteins from soluble cy-
toplasmic proteins, a cytoplasmic
fraction from 2 3 105 cells was
electrophoresed in parallel with
a sample of nuclear matrix from
6 3 105 cells derived from the
same fibroblast preparation and
probed after transfer with an antibody against the cytoplasmic protein b-tubulin. While b-tubulin was abundant in the cytoplasmic frac-
tion (lane 7), no protein band with a similar migration could be detected in the nuclear matrix fraction (lane 8) even after long exposure
times. An antibody against lamin B used to probe fibroblast nuclear matrix proteins produced a band at the appropriate position, veri-
fying the presence of a predicted nuclear matrix protein (lane 9). (B) PCR analysis of protein 4.1 mRNA containing AUG-1 in WI38 fi-
broblasts. The products of reverse transcriptase–PCR using primers encompassing AUG-1 were analyzed on a polyacrylamide gel. The
following cDNAs were amplified: lane 1, WI38 cells; lane 2, human reticulocytes; lane 3, no DNA. The sizes of molecular weight stan-
dards are: 1353, 1078, 872, 603, 310, 234, and 194 bp.The Journal of Cell Biology, Volume 137, 1997 284
determined that the protein expressed by the epitope-
tagged construct was recognized on Western blot analysis
both by antibodies against 4.1 (24-2 IgG, Fig. 8 A, lane 1;
10-1 IgG, data not shown) and KT3 antibody directed
against the epitope tag (Fig. 8 A, lane 2). As expected, the
KT3 antibody did not react with proteins in extracts of
the recipient host fibroblasts (Fig. 8 A, lane 3). To confirm
the presence of endogenous nuclear 4.1 in murine fibro-
blasts, 3T3 cells were probed with anti-RBC 80-kD 4.1.
The 3T3 nuclei displayed punctate immunofluorescent 4.1
signals (Fig. 8 B) similar in pattern to diploid human fibro-
blasts (Fig. 3). After transient transfection with the vector
encoding the 4.1-tagged construct, expressed protein bear-
ing the epitope tag produced a very strong immunofluo-
rescent signal in the nuclei of the 3T3 cells (Fig. 8, C and
C9) when probed with KT3 antibody. Of note, in parallel
experiments, no immunofluorescent signal was detected
when cells were transfected with the vector not containing
the construct (Fig. 8, D and D9) or in mock (i.e., no vector
DNA) transfected cells (data not shown).
Dynamic Rearrangement of 4.1 Epitopes during the
Cell Cycle
During mitosis, the nucleoskeleton is dismantled, a mitotic
spindle is assembled, and chromatin is condensed, pack-
aged, and partitioned into daughter nuclei. Nuclear struc-
tural proteins change their subcellular localizations and
some vary their roles during these events. The rearrange-
ments of protein 4.1 epitopes as cells enter mitosis were
determined in rapidly proliferating CaSki cells. Cells were
labeled with antibody probes to 4.1 peptide epitopes (Fig.
9, A, C, E, and G) and with B4A11, a monoclonal anti-
body against a nuclear matrix protein associated with a
subset of RNA splicing factor storage/assembly sites (Fig.
9, B, D, F, and H) (Blencowe et al., 1994). B4A11 epitopes
produce a strong speckled staining pattern in interphase
nuclei that almost completely disappears in detergent-
extracted cells undergoing mitosis (Blencowe et al., 1994);
cells undergoing mitosis were thus identifiable by the loss
of B4A11 epitopes along with altered morphology.
Antibodies to 4.1 epitopes exhibited a pattern of diffuse
nuclear staining with dispersed intense fluorescent foci
within interphase nuclei (Fig. 9 A, arrow I; see also C, E,
and G) and stained structures resembling centrosomes in
the perinuclear region (Fig. 9 A, below arrow I). This pat-
tern dramatically altered during metaphase, when 4.1 anti-
bodies intensely stained the spindle and spindle pole of the
mitotic apparatus (Fig. 9 A, arrow M and inset) and dif-
fusely stained the outlying areas of the dividing cell. As the
Figure 8. Expression of epitope-tagged 4.1 in nuclei after transient transfection. A construct was engineered to encode the sequences
for red cell 80-kD protein 4.1 fused to an epitope tag derived from SV-40 large T antigen. (A) The construct was bacterially expressed,
isolated, and then analyzed by Western blotting to confirm the presence of both 4.1 and SV-40 tag epitopes. Both 24-2 IgG (lane 1) and
KT3 antibody (against the epitope tag; lane 2) recognized a protein with the same apparent molecular mass. The KT3 antibody did not
recognize epitopes in a whole cell lysate of 3T3 cells (lane 3). (B) Murine fibroblast 3T3 cells, probed with anti-RBC 80-kD 4.1, dis-
played punctate nuclear immunofluorescent signals. (C and C9) 3T3 cells, transiently transfected with pSV40NeoCMV containing se-
quences encoding epitope-tagged RBC 80-kD 4.1, strongly expressed epitope-tagged protein localized in nuclei, which was detected by
indirect immunofluorescence using KT3 antibody. (D and D9) After parallel transient transfection of 3T3 cells with pSV40NeoCMV
without a construct inserted, there was no immunofluorescent staining with KT3 antibody. Bar: (B and B9) 12 mm; (C–D9) 20 mm.Krauss et al. Structural Protein 4.1 in the Nucleus 285
spindle poles separated, 4.1 epitopes clustered around two
distinct perichromosomal regions beginning to egress to-
ward each daughter cell (Fig. 9, C, E, and G). During telo-
phase, 4.1 antigenic material formed an intensely staining
mass in each nascent nucleus and the midbody region in
the vestigial connection between the daughter cells showed
a distinct band of fluorescence. B4A11 epitopes, which had
completely disappeared during mitosis (Fig. 9 B), began to
form larger foci during telophase (Fig. 9 H) preceding
movement into maturing interphase nuclei. The patterns
of 4.1 epitope distribution during the cell cycle were repro-
ducibly observed in cell populations partially synchronized
by a thymidine block. Thus, throughout the cell cycle, 4.1
epitopes remain accessible to antibody binding but display
a complex pattern of rearrangements, migrating from in-
tranuclear sites after interphase to regions associated with
the mitotic spindle, perichromosomal areas, and the mid-
body.
Discussion
While mature red cells contain predominantly an 80-kD
4.1 isoform, multiple protein 4.1 isoforms are expressed in
nucleated erythroid and nonerythroid cells. Combinatorial
alternative splicing of 4.1 mRNAs could in principle gen-
erate many 4.1 isoforms that participate in distinct sets of
molecular interactions. This could provide mechanisms for
differential cellular localization of 4.1 isoforms as well as
isoform functional specificity. There are numerous prece-
dents for a role of alternative splicing in isoform-specific
localization. Among membrane skeletal proteins, for ex-
ample, band 3 isoforms with different 59 ends generated by
alternative transcription initiation localize either to pe-
ripheral membranes or to perinuclear regions (Cox et al.,
1995). Similarly, two b-spectrin isoforms having different
carboxy termini appear to interact with different binding
partners and exhibit different cellular localization (Mal-
chiodi-Albedi et al., 1993). Alternative splicing of CaM ki-
nase generates a nuclear localization signal that targets a
specific isoform of this multifunctional protein to the nu-
cleus (Srinivasan et al., 1994). Alternative splicing of WT1
determines if a WT1 isoform associates within the nucleus
mainly with RNA splicing factors or with DNA in tran-
scription factor domains (Larsson et al., 1995).
Figure 9. Dynamic redistribution of protein 4.1 antigens during
the cell cycle. CaSki cells were permeabilized with 0.5% Triton
X-100 in CSK buffer to remove membranes and soluble proteins
before formaldehyde fixation, incubated with DNase I, and ex-
tracted with 0.25 M ammonium sulfate. The cell preparations
were immunostained with protein 4.1 antibody 24-2 (A, C, E, and
G) and with B4A11 (B, D, F, and H), a monoclonal antibody
against a nuclear matrix protein that displays an intense nuclear
speckle pattern at interphase but is not detectable at mitosis (Blen-
cowe et al., 1994). Micrograph pairs show the fluorescent pattern
with anti–24-2 (left) and B4A11 (right) of the same fields. Cell cy-
cle stages were also confirmed by viewing cells using phase con-
trast microscopy (not shown). (A) In the center, a mitotic cell
(M) showed staining of the mitotic spindle with particularly
strong staining of the spindle poles. The mitotic cell is surrounded
by interphase cells. Note that at opposite sides of an interphase
nucleus (I), immunostained centrosomes (small spots) are visible.
The inset shows the mitotic spindle of another cell intensely im-
munolabeled by anti–10-1. (B–F) Epitopes for B4A11 have dis-
appeared in mitotic cells, but a strong speckled staining pattern is
present in interphase nuclei. (C) In the center, a cell in anaphase
retained a high degree of 4.1 staining in the area of the condensed
chromosomes. (E) As the cells approached telophase and cytoki-
nesis, the bridge between the intensely stained perichromosomal
regions became visible by antibody deposition. As the daughter
cells separated further apart (G), bright 4.1 staining appeared at
the midbody (arrow). In the companion B4A11 fields, diffuse
staining began to condense into a more focal pattern, foreshad-
owing the appearance of the prominent B4A11 speckles charac-
teristic of interphase cells. Bar, 5 mm.The Journal of Cell Biology, Volume 137, 1997 286
The focus of the present investigations has been to ex-
plore in depth the 4.1-immunoreactive epitopes in the nu-
cleus. A currently evolving view is that the nucleus con-
tains a highly structured internal skeletal lattice that can
organize chromosomes and numerous other nuclear com-
ponents into physical and functional subdomains. At a bio-
chemical level, this internal nuclear structure could serve
as a nonsoluble integrator of nuclear metabolic reactions
(Nickerson et al., 1995). Isoforms of protein 4.1 may con-
tribute to nuclear structure. The nucleus houses potential
binding partners for 4.1, such as spectrin (Bachs et al.,
1990; Beck et al., 1994), actin (Nakayasu and Ueda, 1986;
Milankov and DeBoni, 1993; Chaly, N., and X. Chen. 1995.
Mol. Biol. Cell. 6:423a), myosin (Berrios and Fisher, 1986;
Hagen et al., 1986; Milankov and DeBoni, 1993), and cal-
modulin (Bachs et al., 1990). Moreover, protein 4.1 is known
to be glycosylated and phosphorylated in vivo, posttransla-
tional modifications used by nuclear proteins to modulate
interactions during the cell cycle.
An important strategy was to use a panel of affinity-
purified antipeptide IgGs against distinct areas of the 4.1
polypeptide sequence as well as traditional IgG prepara-
tions generated against red cell 80-kD 4.1. The peptides
were selected in part because of their evolutionary conser-
vation and in part because they are encoded in different
functional domains of 4.1. Each antibody preparation re-
acted with red cell 80-kD 4.1 by Western blotting of hu-
man red cell membranes and immunofluorescent staining
of human red cells. Members of the antibody panel consis-
tently showed immunoreactivity with fibroblast nuclear
structures using multiple immunofluorescent protocols,
by Western blot analysis and immunoelectron microscopy.
To avoid potential immunological cross-reactivity with
known members of the 4.1 superfamily (ezrin, moesin, ra-
dixin, merlin/schwannonin, talin, and certain tyrosine phos-
phatases), antibodies used in this study were directed
against domains of 4.1 not shared with these related pro-
teins. Thus, the 4.1 epitopes located in nuclear regions should
identify authentic 4.1 isoforms or very highly related ho-
mologues yet to be discovered.
However, to further verify by an independent approach
that protein 4.1 can localize to the nucleus, fibroblasts were
transiently transfected with a vector encoding the 80-kD
red cell 4.1 sequence fused to an epitope tag. This 4.1 iso-
form coding sequence was selected for a number of rea-
sons: (a) It encodes a well-characterized full-length 4.1 iso-
form; (b) antibody against this sequence produced strong
nuclear immunofluorescent signals in human and murine
fibroblasts; (c) protein bands migrating z80 kD were de-
tected in nuclear matrix Western blots; and (d) this se-
quence contains a potential nuclear localization signal (De
Carcer et al., 1995). This transfection experiment allowed
the unequivocal demonstration that an individual 4.1 iso-
form of known structure can be localized to the nucleus.
Since 4.1 in red cells mechanically links the spectrin and
actin membrane skeleton to the overlying lipid bilayer, we
explored its intranuclear localization to test the idea that
nuclear 4.1 might associate with the nuclear membrane–
lamin region. By reconstructing three-dimensional optical
sections through the nucleus, we found that 4.1 epitopes
are not predominantly colocalized with nuclear membrane
pores or with the underlying fibrous lamin network but are
distributed throughout the interior of the nucleus.
Additional double-label experiments were performed to
test for colocalization of 4.1 with known intranuclear struc-
tural or functional domains. The 4.1 distribution is com-
plex and does not precisely colocalize with PCNA. Double-
label confocal microscopy provided evidence for a potential
association of 4.1 with SC-35–enriched splicing assemblies,
which in fibroblasts are concentrated in a plane just below
the midline, parallel to the growth surface (Carter et al.,
1993). This potential association, however, is not exclu-
sive: 4.1 foci are detected at lower and upper regions of the
nucleus and some 4.1 signals are noncoincident even
within the spliceosomal plane. Taken together, these data
may represent a composite of several functionally distinct
4.1 protein isoforms or could suggest a more unified role
for protein 4.1 at interfaces between the nucleoskeleton
and subnuclear assemblies such as centers for splicing or
DNA replication. However, many nuclear subdomains, in-
cluding DNA replication foci, change in size and distribu-
tion during S phase (D’Andrea et al., 1983; Goldman et al.,
1984; Hatton et al., 1988; O’Keefe et al., 1992), and it is not
known whether protein 4.1 associations are static or dy-
namic during interphase. Therefore, further studies using
tightly synchronized cell cultures and specific inhibitors
will be required to quantitate the spatial associations of 4.1
with these key nuclear functional domains.
After extensive biochemical extraction, 4.1 epitopes were
detected in nuclear matrix preparations by both immuno-
fluorescence light microscopy and immunogold electron
microscopy. At the higher resolution of electron micros-
copy, gold bead–coupled antibodies did not cluster prefer-
entially near the nuclear pore–lamina complex, consistent
with our double-label immunofluorescent confocal data.
Rather, gold beads were distributed in the vicinity of dense
bodies within the internal fibrous nuclear scaffold net-
work. This observation is also entirely consistent with the
double-label immunofluorescence experiments showing
that 4.1 foci appeared at positions within the nuclear area
stained by NuMA but were not primarily coincident. At
the level of resinless electron microscopy, NuMA antibod-
ies have been seen to decorate subsets of filaments in nu-
clear matrix preparations (Zeng et al., 1994); we observed
4.1 epitopes near dense bodies rather than associated with
the surrounding filaments. The biochemical composition
of these dense bodies within the matrix is not entirely un-
derstood. Some contain various combinations of RNA
splicing factors corresponding to speckles seen in immu-
nofluorescence but others appear to be related to centers
of transcription and DNA replication, coiled bodies,
RNA–protein complexes, and nucleolar remnants (for re-
view see Nickerson et al., 1995). It remains to be estab-
lished if 4.1 localization is specific for subclasses of dense
bodies or is more generally associated with a variety of nu-
clear substructures.
Nuclear matrix proteins, isolated from purified fibro-
blast nuclei under extraction conditions identical to those
used for immunofluorescence microscopy, revealed sev-
eral polypeptides that reacted with multiple anti-4.1 IgGs
in Western blots. We speculate that the complex pattern of
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exclusion of various internal peptides as well as posttrans-
lational modifications such as phosphorylation (Horne et
al., 1990; Subrahmanyam et al., 1991) and/or glycosylation
(Haltiwanger et al., 1990). Some additional variation may
be generated by expression of alternative NH2 or COOH
termini not yet characterized. For example, the lack of sig-
nificant reaction of protein 4.1 antibody 24-3 with the
z85-kD band suggests that the sequence of COOH ter-
mini may vary. Similarly, the N-2 IgG prepared against the
209–amino acid NH2-terminal extension of 80-kD 4.1 de-
tected only a single band in the 80–100 kD region with the
slowest migration (z100 kD), indicating that apparently
not all matrix polypeptides have identical NH2 termini.
One of the bands in the z80–100-kD cluster may be
similar to the 4.1p75 polypeptide observed by De Carcer
et al. (1995) using an alternative method of nuclear extrac-
tion and an independently generated 4.1 antibody. More
extensive alternative splicing or usage of new unidentified
promoters may be responsible for lower molecular mass
bands. The broad band in the nuclear matrix preparation
migrating at z55 kD reacted with all the 4.1 IgGs tested.
This pattern could represent an authentic 4.1 isoform that
is the product of an as yet unrecognized 4.1 alternative
splicing pathway, or it could represent a new 4.1 homo-
logue. For example, in the ankyrin membrane skeletal
protein family, a novel small isoform with a truncated
membrane binding domain has been identified in Golgi
(Devarajan et al., 1996). In sum, our final matrix fraction
contains multiple 4.1 isoforms, some with distinct immu-
noreactive patterns. This suggests that 4.1 polypeptides
have differing peptide domains or modifications that may
enable unique molecular interactions in the nucleus.
This speculation is particularly intriguing because dur-
ing mitosis, 4.1 epitopes display dynamic rearrangements
within the nuclear microarchitecture that are correlated
with cell division events: at interphase they reside through-
out the nucleus, then accumulate at the spindle during meta-
phase, coalesce around condensed chromatin during telo-
phase, and some remain at the midbody region during
cytokinesis. Many nuclear-derived components redistrib-
ute at the time of nuclear membrane dissolution to several
structural zones: the chromosome scaffold, the perichro-
mosomal region, the centrosome/kinetochore region, mid-
body, and spindle poles (for review see He et al., 1995).
Some nuclear structural proteins, such as lamin, even mi-
grate into the cytoplasm to be later reimported into newly
formed nuclei. The 4.1 pattern appears to be a unique hy-
brid of several patterns reported for specific matrix-associ-
ated proteins (for review see He et al., 1995).
The recent elucidation of an isoform kindred for struc-
tural protein 4.1 suggests uncharted roles in addition to its
traditionally defined function in the erythroid plasma
membrane skeleton. As a structural component of the nu-
cleus, protein 4.1 presents a new challenge to decipher
mechanisms underlying its targeting to nuclear subdo-
mains, to identify its localized molecular interactions, and
to understand signals orchestrating its dynamic redistribu-
tion during the cell cycle. The versatile rearrangements of
4.1 epitopes during cell division could reflect the disposi-
tion of individual isoforms with unique structural assign-
ments and patterns of expression. Ultimately, protein 4.1
may contribute fundamentally to modulation of the cell
cycle and possibly to more specialized phenomena such as
apoptosis or mammalian erythroid enucleation.
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